266 related articles for article (PubMed ID: 21228429)
1. Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease.
Peyrin-Biroulet L; Oussalah A; Williet N; Pillot C; Bresler L; Bigard MA
Gut; 2011 Jul; 60(7):930-6. PubMed ID: 21228429
[TBL] [Abstract][Full Text] [Related]
2. Natural history of Crohn's disease in a population-based cohort from Cardiff (1986-2003): a study of changes in medical treatment and surgical resection rates.
Ramadas AV; Gunesh S; Thomas GA; Williams GT; Hawthorne AB
Gut; 2010 Sep; 59(9):1200-6. PubMed ID: 20650924
[TBL] [Abstract][Full Text] [Related]
3. [Long term evolution of corticodependant and corticoresistant Crohn's disease patients treated by azzathioprine].
Karoui S; Hamrouni A; Bibani N; Serghini M; Boubaker J; Filali A
Tunis Med; 2011 Jul; 89(7):610-5. PubMed ID: 21780035
[TBL] [Abstract][Full Text] [Related]
4. Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery.
Cosnes J; Nion-Larmurier I; Beaugerie L; Afchain P; Tiret E; Gendre JP
Gut; 2005 Feb; 54(2):237-41. PubMed ID: 15647188
[TBL] [Abstract][Full Text] [Related]
5. Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine.
Dilger K; Schaeffeler E; Lukas M; Strauch U; Herfarth H; Müller R; Schwab M
Ther Drug Monit; 2007 Feb; 29(1):1-5. PubMed ID: 17304143
[TBL] [Abstract][Full Text] [Related]
6. Predictors of infliximab failure after azathioprine withdrawal in Crohn's disease treated with combination therapy.
Oussalah A; Chevaux JB; Fay R; Sandborn WJ; Bigard MA; Peyrin-Biroulet L
Am J Gastroenterol; 2010 May; 105(5):1142-9. PubMed ID: 20389296
[TBL] [Abstract][Full Text] [Related]
7. [Cytomegalovirus primary infection in a patient with Crohn's disease treated with azathioprine and anti-TNF alpha].
Ben Hriz F; Habbessi H; Maamouri N; Belkahla N; Ouerdiane S; Chouaib S; Ouerghi H; Chaabouni H; Ben Mami N
Tunis Med; 2009 Aug; 87(8):545-6. PubMed ID: 20180364
[No Abstract] [Full Text] [Related]
8. [Therapy of chronic inflammatory bowel diseases. TNF-alpha blocker in Crohn disease: earlier use is rewarding].
MMW Fortschr Med; 2008 Dec; 150(51-52):54-5. PubMed ID: 19156959
[No Abstract] [Full Text] [Related]
9. [From research to clinic: The case of Crohn's disease and Tumor Necrosis Factor].
Pellicano R
Minerva Gastroenterol Dietol; 2000 Jun; 46(2):131-8. PubMed ID: 19320082
[No Abstract] [Full Text] [Related]
10. Mucosal healing with methotrexate in Crohn's disease: a prospective comparative study with azathioprine and infliximab.
Laharie D; Reffet A; Belleannée G; Chabrun E; Subtil C; Razaire S; Capdepont M; de Lédinghen V
Aliment Pharmacol Ther; 2011 Mar; 33(6):714-21. PubMed ID: 21235604
[TBL] [Abstract][Full Text] [Related]
11. [Which place for methotrexate in treatment of luminal Crohn's disease?].
Carbonnel F
Gastroenterol Clin Biol; 2009 Jan; 33(1 Pt 1):18-20. PubMed ID: 19084362
[No Abstract] [Full Text] [Related]
12. [Hodgkin's lymphoma in a patient with Crohn's disease treated with azathioprine and antibodies anti tumor necrosis factor α].
Sagüés M; Navarro JT; Ribera JM; Millá F
Med Clin (Barc); 2012 Apr; 138(8):366-7. PubMed ID: 21752407
[No Abstract] [Full Text] [Related]
13. Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort.
Schnitzler F; Fidder H; Ferrante M; Noman M; Arijs I; Van Assche G; Hoffman I; Van Steen K; Vermeire S; Rutgeerts P
Gut; 2009 Apr; 58(4):492-500. PubMed ID: 18832518
[TBL] [Abstract][Full Text] [Related]
14. Long-term results with azathioprine therapy in patients with corticosteroid-dependent Crohn's disease: open-label prospective study.
Chebli JM; Gaburri PD; De Souza AF; Pinto AL; Chebli LA; Felga GE; Forn CG; Pimentel CF
J Gastroenterol Hepatol; 2007 Feb; 22(2):268-74. PubMed ID: 17295882
[TBL] [Abstract][Full Text] [Related]
15. 6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.
Roblin X; Serre-Debeauvais F; Phelip JM; Faucheron JL; Hardy G; Chartier A; Helluwaert F; Bessard G; Bonaz B
Aliment Pharmacol Ther; 2005 Apr; 21(7):829-39. PubMed ID: 15801918
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment with adalimumab in infliximab-resistant Crohn's disease.
Barthel HR; Gille T; Halbsguth A; Kramer M
J Gastroenterol Hepatol; 2005 Sep; 20(9):1464-5. PubMed ID: 16105142
[No Abstract] [Full Text] [Related]
17. Efficacy and safety of azathioprine maintenance therapy in a group of Crohn's disease patients in China.
Zheng JJ; Chu XQ; Shi XH; Zhou CL; Seng BW
J Dig Dis; 2008 May; 9(2):84-8. PubMed ID: 18419641
[TBL] [Abstract][Full Text] [Related]
18. The use of azathioprine in Crohn's disease during pregnancy and in the post-operative setting: a worldwide survey of experts.
Peyrin-Biroulet L; Oussalah A; Roblin X; Sparrow MP
Aliment Pharmacol Ther; 2011 Mar; 33(6):707-13. PubMed ID: 21251032
[TBL] [Abstract][Full Text] [Related]
19. Longstanding Crohn's vulvitis successfully treated with combined anti-TNFα antibody and azathioprine.
Macdonagh E; Pugh S; Fox R
J Obstet Gynaecol; 2013 Jul; 33(5):530. PubMed ID: 23815219
[No Abstract] [Full Text] [Related]
20. [Miliary tuberculosis in a patient with Crohn's disease].
Ferrer I; Maroto N; Montón C; Villagrasa R; López A; Clofent J; Hinojosa J
Gastroenterol Hepatol; 2011; 34(7):511-3. PubMed ID: 21737181
[No Abstract] [Full Text] [Related]
[Next] [New Search]